IRIS
ORSI, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.275
NA - Nord America 1.071
AS - Asia 971
SA - Sud America 168
Continente sconosciuto - Info sul continente non disponibili 103
AF - Africa 17
OC - Oceania 8
Totale 3.613
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.012
RU - Federazione Russa 669
IT - Italia 317
SG - Singapore 304
CN - Cina 301
BR - Brasile 139
HK - Hong Kong 107
VN - Vietnam 87
BD - Bangladesh 69
DE - Germania 52
FR - Francia 44
SE - Svezia 43
GB - Regno Unito 41
CA - Canada 33
IN - India 32
NL - Olanda 25
PL - Polonia 18
FI - Finlandia 17
MX - Messico 16
AR - Argentina 15
ES - Italia 12
JP - Giappone 10
ZA - Sudafrica 10
AT - Austria 8
AU - Australia 8
TR - Turchia 7
AE - Emirati Arabi Uniti 6
ID - Indonesia 6
KR - Corea 6
EC - Ecuador 5
IE - Irlanda 5
IQ - Iraq 5
PK - Pakistan 5
BH - Bahrain 4
MY - Malesia 4
AL - Albania 3
BE - Belgio 3
CO - Colombia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
LT - Lituania 3
VE - Venezuela 3
DK - Danimarca 2
HN - Honduras 2
HR - Croazia 2
IR - Iran 2
JM - Giamaica 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
TH - Thailandia 2
TW - Taiwan 2
UA - Ucraina 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
LK - Sri Lanka 1
MD - Moldavia 1
MV - Maldive 1
NG - Nigeria 1
PR - Porto Rico 1
QA - Qatar 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZW - Zimbabwe 1
Totale 3.511
Salva come PNG Salva come JPEG
Città #
Singapore 194
Moscow 149
Dallas 130
Ashburn 123
Hong Kong 104
San Jose 102
Milan 70
Beijing 53
New York 44
Shanghai 44
Council Bluffs 42
Boardman 36
Los Angeles 33
Santa Clara 33
Hefei 31
Lauterbourg 30
Rome 28
Ho Chi Minh City 27
Hanoi 22
Warsaw 18
Naples 16
Cesano Boscone 14
Chicago 12
Orem 12
Brescia 11
Brooklyn 11
London 11
Amsterdam 10
Buffalo 10
Nuremberg 10
Phoenix 10
Stockholm 10
São Paulo 10
Boston 9
Chennai 9
Helsinki 9
Munich 9
Campinas 8
Frankfurt am Main 8
Mexico City 8
Montreal 8
New Orleans 8
Seattle 8
Tokyo 8
Atlanta 7
Bologna 7
Lawrence 7
Mumbai 7
Princeton 7
Rio de Janeiro 7
Toronto 7
Caxias do Sul 6
Denver 6
Falkenstein 6
Hyderabad 6
Johannesburg 6
Manchester 6
Perugia 6
Sydney 6
Carlsbad 5
Haiphong 5
Houston 5
Lappeenranta 5
Miami 5
Pisa 5
The Dalles 5
Turin 5
Vienna 5
Washington 5
Brasília 4
Dhaka 4
Dublin 4
Florence 4
Guangzhou 4
Las Vegas 4
Manama 4
Palermo 4
San Francisco 4
Baton Rouge 3
Bellpuig 3
Brussels 3
Charlotte 3
Da Nang 3
Dubai 3
Essen 3
Fermo 3
Figino 3
Fortaleza 3
Fuzhou 3
Hangzhou 3
Mezzolombardo 3
Milton Keynes 3
New Delhi 3
New Haven 3
Ottawa 3
Poplar 3
Porto Alegre 3
Prague 3
Querétaro 3
Reggio Emilia 3
Totale 1.801
Salva come PNG Salva come JPEG
Nome #
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 194
ANALYSIS OF THE ACTIVITY OF NOVEL RADIOSENSITIZERS AND SYSTEMIC TREATMENTS IN PANCREATIC ADENOCARCINOMA: A ROAD MAP TO IMPROVE THE OUTCOME IN LOCALLY ADVANCED DISEASE. 161
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 158
Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology 156
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants 137
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 134
DIAGNOSTIC DELAY AT DIAGNOSIS AND TIME-TO-TREATMENT INFLUENCE OVERALL SURVIVAL OF PANCREATIC CANCER PATIENTS 128
A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants 126
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 123
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 114
Cyclophosphamide maintenance to extend combination chemotherapy-free interval in metastatic pancreatic ductal adenocarcinoma 103
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 102
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence 102
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes 97
Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients 94
Lessons and open questions in borderline resectable pancreatic cancer 93
Extensive molecular reclassification: new perspectives in small bowel adenocarcinoma? 93
Isolated lung metastases from pancreatic ductal adenocarcinoma (PDAC): Diagnostic and therapeutic challenges of a different disease 91
The impact of nutritional status on pancreatic cancer therapy 90
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 90
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey. 90
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 89
ANGPT2 and NOS3 polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients receiving sorafenib 86
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI) 85
Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma 83
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples 82
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 80
Is the Delphi's Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma? 75
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 69
Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial 66
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 66
Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variants 64
Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma 58
Pancreatic cancer: still a cold case? 56
The Role of Neoadjuvant FOLFIRINOX in Borderline Resectable Pancreatic Cancer: A Network Meta-Analysis 52
Long-term Outcomes of EUS-guided Gastroenterostomy (LONG-RANGE study): a prospective cohort study tracking symptom recurrence, reintervention timelines and stent modifications over time. 38
Long-term Outcomes of endoscopic ultrasound-guided Gastroenterostomy (LONG-RANGE study): a prospective cohort study tracking symptom recurrence, reintervention timelines and stent modifications over time 28
Exploring external validity of chemotherapy for pancreatic ductal adenocarcinoma in real life 27
Pancreatic adenocarcinoma nutritional-clinical index (PANCIN): A novel prognostic tool in advanced pancreatic cancer. 15
Clinical implications and biomarkers in the PACT-21 CASSANDRA trial – Authors' reply 11
Management of Patients with Suspected Hypersensitivity to Chemotherapy Drugs: A Practical Approach in a Tertiary Care Setting 7
Totale 3.613
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.775
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.775
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20229 0 0 0 0 0 0 0 5 3 0 0 1
2022/202368 14 11 5 0 1 16 3 10 2 0 6 0
2023/2024157 12 9 12 31 15 18 5 15 4 10 5 21
2024/2025575 39 11 19 22 29 59 85 76 56 65 54 60
2025/20262.414 190 160 130 254 215 79 190 187 639 141 110 119
2026/2027390 229 161 0 0 0 0 0 0 0 0 0 0
Totale 3.613